Table 5.
Samples | ERɑ | ERβ | ERɑ | ERβ | Estradiol pg/ml |
---|---|---|---|---|---|
(mRNA) | (Protein) | ||||
SLE-1 | 0.036 | 0.811 | 0.62 | 0.61 | 166.3 |
SLE-2 | 0 026 | 0.170 | 0.35 | 0.85 | 98.7 |
SLE-3 | 0.018 | 0.443 | 0.93 | 0.80 | 90.3 |
SLE-4 | 0.027 | 0.442 | 0.29 | 0.67 | 86.4 |
SLE-5 | 0.083 | 1.365 | 0.40 | 0.87 | 128.7 |
SLE-6 | 0.071 | 0.370 | 1.00 | 0.90 | 84.5 |
SLE-7 | 0.015 | 0.660 | 0.31 | 0.65 | 98.4 |
SLE-8 | 0 024 | 0.600 | 0.80 | 0.98 | 123.7 |
SLE-9 | 0.238 | 18.15 | 0.76 | 0.98 | 111.6 |
Median | 0.027 | 0.60 | 0.62 | 0.85 | 98.7 |
Blood samples were drawn from SLE patients (n = 9) and T cells were purified by negative selection. ER subtype mRNA was measured by real-time PCR and protein in the same T cell sample was quantified by Western blotting. Plasma estradiol was measured at the time of blood draw. The levels of hormone in circulation were within the normal range for women with regular menstrual cycles.
SLEDAI, systemic lupus disease activity index.